聚焦艾昆纬-340B合同药房真的能“增加340B患者的可及性”吗?(英)-2025。Do 340B Contract Pharmacies Really “Increase Access” for 340B Patients?WILLIAM SARRAILLE, JD, University of Maryland Francis King Carey School of Law SHANYUE ZENG, MA, IQVIA Market Access Technology Solutions RORY MARTIN, PHD, IQVIA Market Access Technology Solutions。
聚焦艾昆纬-340B合同药房真的能“增加340B患者的可及性”吗?(英)-2025。Do 340B Contract Pharmacies Really “Increase Access” for 340B Patients?WILLIAM SARRAILLE, JD, University of Maryland Francis King Carey School of Law SHANYUE ZENG, MA, IQVIA Market Access Technology Solutions RORY MARTIN, PHD, IQVIA Market Access Technology Solutions。
聚焦艾昆纬-340B合同药房真的能“增加340B患者的可及性”吗?(英)-2025。Do 340B Contract Pharmacies Really “Increase Access” for 340B Patients?WILLIAM SARRAILLE, JD, University of Maryland Francis King Carey School of Law SHANYUE ZENG, MA, IQVIA Market Access Technology Solutions RORY MARTIN, PHD, IQVIA Market Access Technology Solutions。
覆盖 2026 年,全文共 14 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
适合战略规划、产品经理等读者参考。
重点分析了艾昆纬等议题。